What "response" and "remission" actually mean here
Two outcomes carry most of the weight in this research. "Response" means a person's depression score dropped enough to count as a meaningful improvement; "remission" means the symptoms fell to a level close to no depression at all. Remission is the stricter bar, and it is the one patients and clinicians usually care about most.
In the pooled trials, bright light therapy came out ahead on both. Remission reached 40.7% with bright light versus 23.5% without it, and response reached 60.4% versus 38.6% [2]. In plain terms, roughly one extra person in six crossed into remission when light was added, and about one extra person in five showed a clear response. Those are averages across trials, not a promise for any single patient.
The benefit shows up early and holds later
Timing matters because depression treatment is often judged by how quickly someone turns a corner. When the trials were split by how long people had been treated, bright light looked strongest in the shorter window. Within four weeks, remission was 27.4% with bright light versus 9.2% without, and response was 55.6% versus 27.4% [2].
The advantage did not vanish with longer follow-up, but it narrowed. Beyond four weeks, remission was 46.6% versus 29.1% and response was 63.0% versus 44.9% [2]. One reading is that light may speed up the initial response to treatment, though the authors present that as a suggestion rather than a demonstrated mechanism [2]. A separate review likewise reports that bright light improves response and remission rates in nonseasonal depressive disorders [1].
What bright light was actually tested against
This is where the answer needs a qualifier. The trials in the pooled analysis compared bright light against dim red light or against an antidepressant taken alone [2]. Dim red light is a useful placebo because it looks like a light box but delivers little of the therapeutic brightness, so beating it shows the brightness itself is doing something. Beating an antidepressant alone shows light adds something on top of medication.
Neither design is quite the same as comparing bright light plus a full standard-treatment program against that same program without light. So the honest summary is that bright light beats a placebo light and beats medication alone, which is strong evidence that it helps, but the precise added benefit over a complete standard package is not directly measured in these trials [2]. A related review of blue-light therapy found no significant difference in response or remission between blue-light conditions and inactive or active light comparisons, a reminder that not every light-based approach performs identically [5].
Who was studied, and what is still unsettled
The pooled evidence comes from adults with nonseasonal depression, and the participants were predominantly women, about three-quarters of the 858 patients [2]. That skew is worth keeping in mind when generalizing to men or to groups not well represented in the trials.
Smaller and narrower studies add texture but not a clean answer to the comparison question. A randomized trial in college students with subthreshold depression compared different light intensities against a waiting list and reported response and remission rates, but it did not test light against standard treatment [4]. Reviews of bright light in nonseasonal depression report improved response and remission overall without clearly isolating a comparison to standard care alone [1][3]. The practical takeaway is that bright light looks like a low-risk add-on with a real, measurable edge, while the exact size of that edge over a full standard-treatment regimen remains an open question.
Sources used in this answer
In nonseasonal depressive disorders, bright light therapy improves response and remission rates
Bright light therapy improves response and remission rates in nonseasonal depressive disorders, though the paper does not clearly describe a comparison with standard treatment alone.
Bright Light Therapy for Nonseasonal Depressive Disorders
As an adjunctive treatment for nonseasonal depression, bright light produced higher remission (40.7% vs 23.5%) and response (60.4% vs 38.6%) rates than dim red light or antidepressant monotherapy, with the advantage largest at under four weeks.
Bright Light Therapy Is Effective for Nonseasonal Depressive Disorders
Bright light therapy is reported as effective for improving remission and response in nonseasonal depressive disorders, without a clear comparison to standard treatment alone.
Efficacy of light therapy for a college student sample with non-seasonal subthreshold depression: An RCT study
In college students with nonseasonal subthreshold depression, an 8-week randomized trial of different light intensities versus a waiting-list control reported response and remission rates based on HAMD-24 scores.
Blue-light therapy for seasonal and non-seasonal depression: a systematic review and meta-analysis of randomized controlled trials
Blue-light therapy showed no significant differences in response or remission rates compared with inactive or active light conditions and was generally well tolerated.